Mindstrong Health is a technology company.
Mindstrong Health has raised $131.0M across 2 funding rounds.
Mindstrong Health has raised $131.0M in total across 2 funding rounds.
Mindstrong Health has raised $131.0M in total across 2 funding rounds.
Mindstrong Health's investors include BITKRAFT Ventures, Counterview Capital, Courtside Ventures, Matt Ocko, DST Global, Five Sigma, Footwork, General Catalyst, GSV Acceleration, Nex Cubed, NextView Ventures, QB1 Ventures.
Mindstrong Health is a digital mental health company that developed a virtual platform combining evidence-based care, data analytics, and smartphone technology to deliver measurement-based care (MBC) for mental health conditions, including serious mental illness like depression, schizophrenia, and substance abuse.[1][2][4] It serves patients, providers, and healthcare systems by passively tracking smartphone behaviors—such as typing patterns, swipes, and app usage—via digital phenotyping to enable early detection, personalized treatment plans, progress tracking, and relapse prevention, ultimately aiming to improve outcomes while reducing costs.[1][3][4][5] The platform empowers members through mobile assessments, data-empowered care plans (DECPs), and virtual therapy/psychiatry, with early traction including clinical trials and contracts with California counties worth ~$60 million over four years.[4][7]
Founded in 2014 and headquartered in Mountain View, CA, Mindstrong grew to over 200 employees, focusing on high-risk populations before pivoting from pure biomarker tech to integrated virtual care.[4][5][7][8] However, by 2023, the company ceased operations amid challenges in the U.S. health system's reimbursement for mental health tech, highlighting limits in scaling app-based models without sustainable payer support.[8]
Mindstrong Health was founded in 2014 by a team including Dr. Thomas R. Insel, former director of the National Institute of Mental Health (NIMH), who brought expertise in mental health biomarkers and technology's potential to transform care.[5][7] The idea emerged from recognizing mental health's lack of objective measures—like biomarkers in other fields—and leveraging ubiquitous smartphones (over 3 billion globally) for "digital phenotyping" to track subtle behavioral signals, such as keyboard dynamics and interactions, for early detection of conditions like depression.[4][5]
Early traction came from rigorous clinical studies validating the tech, including five years of data showing predictive capabilities (e.g., forecasting mood a week ahead) and partnerships like a 5,000-person trauma center study for PTSD prediction.[4][5] Pivotal moments included shifting from biomarker research to a full virtual clinic model with therapy and psychiatry, securing county contracts, and publishing peer-reviewed research, though this evolution couldn't overcome market hurdles leading to the company's demise by 2023.[4][8]
Mindstrong rode the wave of digital health and AI in mental wellness, pioneering digital phenotyping amid rising smartphone penetration and demand for scalable mental health solutions post-2010s awareness shifts.[4][5] Timing was ideal with 3 billion smartphones enabling global access, addressing access gaps, stigma, and poor outcomes in mental health—fields lacking biomarkers unlike physical medicine.[5]
Market forces like telehealth booms (accelerated by COVID-19) and payer interest in cost-saving tech favored it, influencing ecosystems through clinical validations, county adoptions, and research that advanced AI applications in behavioral health.[4][8] Yet, it exposed reimbursement realities: high consumer value for mental health evaporates at payment point, prompting industry reflection on blending tech with human clinicians for sustainable models.[8]
Mindstrong's closure underscores a harsh lesson—innovative tech alone can't conquer U.S. healthcare economics without robust reimbursement—yet its biomarker research and MBC framework endure as blueprints for resilient digital mental health platforms.[8] Next evolutions may see successors expand modalities (e.g., voice analysis) toward preventive care, leveraging larger datasets and AI for global scale, as Insel envisioned: early detection transforming mental health like digital tools revolutionized other medicine.[4][5]
Tying back, while Mindstrong's virtual platform promised to empower those with mental challenges through data and care, its story highlights the need for tech to align with systemic realities for lasting impact.[1][8]
Mindstrong Health has raised $131.0M across 2 funding rounds. Most recently, it raised $100.0M Series C in May 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2020 | $100.0M Series C | BITKRAFT Ventures, Counterview Capital, Courtside Ventures, Matt Ocko, DST Global, Five Sigma, Footwork, General Catalyst, GSV Acceleration, Nex Cubed, NextView Ventures, QB1 Ventures, Quiet Capital, Reach Capital, Renegade Partners, Rosecliff Ventures, Shasta Ventures, SignalFire, SV Angel, Uncork Capital, Uprising, What If Ventures, Colin Carrier, David Jeske, Jason Citron, Jason Robins, Joe Greenstein, Jon Goldman, Julian Shapiro, Rohit Gupta, Ryan Melohn | |
| Dec 1, 2018 | $31.0M Series B | Matt Ocko, DST Global, Five Sigma, Footwork, General Catalyst, GSV Acceleration, NextView Ventures, Quiet Capital, Reach Capital, Renegade Partners, Shasta Ventures, SignalFire, SV Angel, Uncork Capital, Uprising, David Jeske, Jason Citron, Joe Greenstein, Julian Shapiro |